Current Opinion in Lipidology, 1473-6535

Journal

More filtering options
  1. 2019
  2. Atherosclerosis: cell biology and lipoproteins

    Daniel Engelbertsen, Sara Rattik & Harry Björkbacka, 2019, In : Current Opinion in Lipidology. 30, 1, p. 50-52 3 p.

    Research output: Contribution to journalArticle

  3. 2016
  4. Atherosclerosis: cell biology and lipoproteins.

    Eva Bengtsson & Harry Björkbacka, 2016, In : Current Opinion in Lipidology. 27, 1, p. 94-96

    Research output: Contribution to journalDebate/Note/Editorial

  5. 2015
  6. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2015, In : Current Opinion in Lipidology. 26, 1, p. 67-69

    Research output: Contribution to journalDebate/Note/Editorial

  7. 2014
  8. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2014, In : Current Opinion in Lipidology. 25, 4, p. 319-320

    Research output: Contribution to journalDebate/Note/Editorial

  9. 2013
  10. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2013, In : Current Opinion in Lipidology. 24, 3, p. 279-280

    Research output: Contribution to journalDebate/Note/Editorial

  11. 2012
  12. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.

    Jan Nilsson, Harry Björkbacka & Nordin Fredrikson, G., 2012, In : Current Opinion in Lipidology. 23, 5, p. 422-428

    Research output: Contribution to journalArticle

  13. Atherosclerosis: cell biology and lipoproteins.

    Caitriona Grönberg & Harry Björkbacka, 2012, In : Current Opinion in Lipidology. 23, 5, p. 505-508

    Research output: Contribution to journalArticle

  14. 2011
  15. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2011, In : Current Opinion in Lipidology. 22, 1, p. 74-75

    Research output: Contribution to journalArticle

  16. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2011, In : Current Opinion in Lipidology. 22, 5, p. 430-432

    Research output: Contribution to journalArticle

  17. 2010
  18. Atherosclerosis: cell biology and lipoproteins

    Maria Wigren & Harry Björkbacka, 2010, In : Current Opinion in Lipidology. 21, 1, p. 97-98

    Research output: Contribution to journalDebate/Note/Editorial

  19. 2009
  20. Atherosclerosis: cell biology and lipoproteins

    Kolbus, D. & Harry Björkbacka, 2009, In : Current Opinion in Lipidology. 20, 4, p. 355-356

    Research output: Contribution to journalDebate/Note/Editorial

  21. Atherosclerosis: cell biology and lipoproteins.

    Berg, K. & Harry Björkbacka, 2009, In : Current Opinion in Lipidology. 20, 1, p. 82-84

    Research output: Contribution to journalArticle

  22. Shifting to new targets in pharmacological prevention of cardiovascular diseases

    Jan Nilsson & Kovanen, P. T., 2009, In : Current Opinion in Lipidology. 20, 5, p. 361-362

    Research output: Contribution to journalDebate/Note/Editorial

  23. 2008
  24. Atherosclerosis: cell biology and lipoproteins

    Harry Björkbacka, 2008, In : Current Opinion in Lipidology. 19, 2, p. 215-217

    Research output: Contribution to journalDebate/Note/Editorial

  25. Atherosclerosis: cell biology and lipoproteins.

    Harry Björkbacka, 2008, In : Current Opinion in Lipidology. 19, 5, p. 548-549

    Research output: Contribution to journalArticle

  26. Defining the spectrum of alleles that contribute to blood lipid concentrations in humans

    Kathiresan, S., Musunuru, K. & Marju Orho-Melander, 2008, In : Current Opinion in Lipidology. 19, 2, p. 122-127

    Research output: Contribution to journalReview article

  27. Inflammation and immunity in diabetic vascular complications.

    Jan Nilsson, Eva Bengtsson, Nordin Fredrikson, G. & Harry Björkbacka, 2008, In : Current Opinion in Lipidology. 19, 5, p. 519-524

    Research output: Contribution to journalArticle

  28. Lipid metabolism: why is apoM an apolipoprotein?

    Nielsen, L. B. & Björn Dahlbäck, 2008, In : Current Opinion in Lipidology. 19, 6, p. 622-623

    Research output: Contribution to journalArticle

  29. Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys?

    Lisa Berglund, Öhman, J., Zetterqvist, A. & Maria Gomez, 2008, In : Current Opinion in Lipidology. 19, 5, p. 483-490

    Research output: Contribution to journalArticle

  30. 2007
  31. 2006
  32. Apolipoprotein M - a novel player in high-density lipoprotein metabolism and atherosclerosis.

    Björn Dahlbäck & Nielsen, L. B., 2006, In : Current Opinion in Lipidology. 17, 3, p. 291-295

    Research output: Contribution to journalReview article

  33. Multiple roles of Toll-like receptor signaling in atherosclerosis.

    Harry Björkbacka, 2006, In : Current Opinion in Lipidology. 17, 5, p. 527-533

    Research output: Contribution to journalReview article

  34. 2005
  35. Chromatin modification by lipids and lipoprotein components: an initiating event in atherogenesis?

    Zaina, S., Døssing, K., Lindholm, M. & Lund, G., 2005, In : Current Opinion in Lipidology. 16, 5, p. 549-553

    Research output: Contribution to journalReview article

  36. 2004
  37. Will autoantibodies help to determine severity and progression of atherosclerosis?

    Jan Nilsson & Kovanen, P. T., 2004, In : Current Opinion in Lipidology. 15, 5, p. 499-503

    Research output: Contribution to journalLetter

  38. 2003
  39. 2002
  40. Atherosclerosis: cell biology and lipoproteins.

    Ares, M., 2002, In : Current Opinion in Lipidology. 15, 2, p. 581-583

    Research output: Contribution to journalLetter